STELLAPHARM was born to care and protect patient’s health, to help enhancing their lives and living longer. Your health, for today and for future.
Ho Chi Minh City and Geneva, 10 September 2026 – Stellapharm and Medicines Patent Pool (MPP) signed a sublicence agreement to develop, manufacture and supply a generic version of Roche’s baloxavir marboxil, a single-dose antiviral treatment recommended by the World Health Organization (WHO) for influenza. The agreement will allow Stellapharm to manufacture and supply baloxavir
On July 18, 2025, STELLAPHARM J.V. Co., Ltd. – Branch 1 achieved the EU – GMP (Good Manufacturing Practice) certification issued by the competent authority, the Croatian Agency for Medicinal Products and Medical Devices (HALMED) and the information is published on the EudraGMDP database of the European Union. Achieving this certification not only enhances the
Stellapharm J.V. Co., Ltd. – Branch 1 has just been certified by Bureau Veritas Certification – an international certification organization in the field of inspection, testing and certification – compliance with two international standards ISO 14001: 2015 and ISO 45001: 2018 for all pharmaceutical production, distribution and export activities. As a business operating in health
PARIS — Nearly three dozen global pharmaceutical companies, in a letter to the head of the European Commission, demanded help to maintain operations in the EU despite threatened U.S. tariffs on imports, including measures to compensate them for the cost of pharmaceutical innovations, French business newspaper Les Echos reported on Tuesday. In the letter sent
Germany group Siemens said on Wednesday it is buying Dotmatics, a US software company, for $5.1 billion to leverage its use of artificial intelligence to make drug discoveries. Siemens said the acquisition was “complementary” to its expansion into Life Sciences and would lift its game in a market needing more medication innovation as populations age.
LONDON, April 9 (Reuters) – U.S. President Donald Trump late on Tuesday reiterated he would impose tariffs on imports of pharmaceutical products that have long been spared from past trade disputes due to the potential for harm to patients. Trump excluded them from his announcement of sweeping import tariffs last week, but in recent weeks
Commonly used drugs like Novo Nordisk’s Ozempic were exempt from President Donald Trump’s expansive reciprocal tariffs announced earlier this week, which are expected to drive prices up across several industries, though analysts and Trump have warned that future tariffs will likely target imported medicines. Trump imposed a baseline 10% on most U.S. imports in an
ESG (Environmental – Social – Governance) is a set of standards that measure factors related to the sustainable development activities of a business. It includes criteria on the environment, society and corporate governance.Investors can use ESG to select companies that operate effectively and are socially responsible to invest. At the same time, ESG helps businesses
Strengthening decentralization and post-inspection to improve the quality and control the uses of functional foods is the latest direction of the Minister of Health on the functional food market. According to statistics from the Ministry of Health, from 2021 to present, the food market has more than 84,000 common foods; 54,549 functional food products (29,779
HCMC – Vietnam aims to develop its pharmaceutical chemical industry into a high-tech sector integrated into the global pharmaceutical value chain by 2045, targeting annual industrial production growth of 8-11%. Deputy Prime Minister Le Thanh Long has approved a national program to expand domestic production of pharmaceutical ingredients and increase exports of pharmaceutical chemical products.
Akeso’s immunotherapy drug allowed half of its patients to go 11.1 months without their condition worsening Chinese drug maker Akeso, whose new cancer drug has outperformed a leading Western peer in clinical studies, is being hailed as the “DeepSeek moment” for China’s drug industry, as biotech emerges as a new front in the escalating US-China
With high connectivity and spillover, the pharmaceutical industry can contribute to Vietnam’s becoming a high-income country and one of the top industrialised countries in Asia by 2045. In addition to research, innovation, and health improvement, the industry plays an important role in the global economy. It directly contributes $755 billion to global GDP, equivalent to
In recent years, the management of health protection foods and functional foods has become one of the important issues in the food industry in Vietnam. Amendment to Decree 15: Clarifying concepts and regulations on food supplements In recent years, the management of health protection foods and functional foods has become one of the important issues
During a health-focused event in New York on Tuesday, Google announced that it’s developing a collection of “open” AI models for drug discovery called TxGemma. The AI models, which Google said will be released through its Health AI Developer Foundations program later this month, can understand both “regular text” and the structures of different “therapeutic
Vietnam’s pharmaceutical industry has made notable achievements in recent times. The total value of the market has increased from $3.4 billion in 2015 to $7.46 billion in 2022, with an annual growth rate of about 12-15 per cent. Vietnam’s pharmaceutical industry has made notable achievements in recent times. The total value of the market has
In March 11, 2025, the Commission has proposed a Regulation to improve the availability of critical medicines in the EU. The proposal aims to protect human health by incentivising supply chain diversification and boosting pharmaceutical manufacturing in the EU. This will support the EU’s pharmaceutical sector which is a major contributor to our economy. The
By 2030, Việt Nam aims to produce 20 per cent of the raw materials needed for pharmaceutical production, meeting 50 per cent of the demand for functional food and cosmeceutical ingredients domestically. HÀ NỘI — Deputy Prime Minister Lê Thành Long has signed a decision approving a programme to develop the domestic pharmaceutical chemical industry
The trade deal between Vietnam and the EU has been making significant impacts on the home pharma market, driven by tariff reductions, marketing simplifications, and clearer business rights. According to the latest statistics from Vietnam Customs, pharmaceutical imports totalled nearly $4.4 billion last year, up 27.9 per cent from 2023, of which $2.5 billion came
“STELLAPHARM is destined to care for and protect the health of patients and help everyone enhance and ensure their quality of life,” Mr. Van Dung, General Director of STELLAPHARM, proudly said. STELLAPHARM is gradually realizing the dream of bringing quality Vietnamese pharmaceuticals to the world. Mr. Nguyen Van Loi, Secretary of the Binh Duong Provincial
Europe’s pharmaceutical firms are rushing to prepare for the potential fallout of U.S. import duties, with some forming “tariff taskforces,” even as analysts warn that levies on the sector could break global trade rules. Fresenius Medical Care says that it has installed its first-ever “tariff taskforce” to manage uncertainty surrounding U.S. President Donald Trump’s proposed
Việt Nam’s pharmaceutical industry still faces many challenges and difficulties in the context of increasingly deep integration with the world, participants heard at a special seminar in Hà Nội. HÀ NỘI — Việt Nam’s pharmaceutical industry still faces many challenges and difficulties in the context of increasingly deep integration with the world, participants heard at
After more than 5 years of implementation, the Vietnam – EU Free Trade Agreement (EVFTA) has had a strong impact on the Vietnamese economy in general and the pharmaceutical market in particular. EVFTA takes effect from August 1, 2020. The emergence of EVFTA increases the competitiveness between Vietnamese pharmaceutical enterprises and enterprises in the same
A draft version of the revised Pharmacy Law will be presented to the ongoing National Assembly session to enhance public access to new medicines. Only 9% of new medicines have been introduced in Việt Nam over the past decade, far lower than that in other Asia-Pacific countries (20%). The Head of Legal and Integration Department
Following a year of strategic expansion, European medicine-related companies are advancing their operations in Vietnam. Gregoris Charitonos, chairman of the European Standards Medicines Sector Committee under the European Chamber of Commerce in Vietnam, talked to VIR’s Tung Anh about what lies ahead. How have legal changes made impacts on the performance of member companies of
The Ministry of Health has proposed a policy to encourage the transfer of new and innovative drugs, aiming to create more opportunities for patients. According to the ministry’s Drug Administration of Vietnam (DAV), innovative drugs in Vietnam account for only about 3% of the total but represent up to 22% of the value and are
According to preliminary statistics from the General Department of Customs, in the first 6 months of 2024, our pharmaceutical import value reached 1.997.990.548 USD, an increase of 24,1% over the same period in 2023. According to preliminary statistics of the General Department of Customs, pharmaceutical import turnover in June 6 reached 2024 USD, down 348.711.261%
The European Commission’s Health Emergency Preparedness and Response Authority (HERA), working with the Belgian Presidency of the Council of the EU, have today launched the Critical Medicines Alliance at the margins of the informal EPSCO Council meeting of health ministers, as part of the actions to build a strong European Health Union. The Alliance brings
With a population of more than 100 million and a total drug consumption of more than 8 billion USD in 2023, the Vietnamese pharmaceutical market is quite attractive and has a lot of potential for production and business activities. The Ministry of Health said that 2024 is a key year, with the review and amendment
The total value of Vietnam’s pharmaceutical market is estimated at US$7 billion, but the industry faces challenges including low infrastructure and limited financial capacity, insiders have said. Vietnam’s pharmaceutical industry has experienced high growth over the past 10 years, with a compound annual growth rate of 7.3%. According to the Drug Administration of Vietnam under
Continuing the program of the 32nd session, on the afternoon of April 16, the National Assembly Standing Committee gave opinions on the Law Project amending and supplementing a number of articles of the Pharmacy Law. Reporting at the meeting, Minister of Health Dao Hong Lan said that compared to the current law, the draft Law
The version grants pharmaceutical business licenses to non-profit pharmaceutical entities that engage in commercial activities to ensure essential medicines reach a wider range of the population. HÀ NỘI — A revised version of the Law on Pharmaceuticals 2016 will be presented to the National Assembly for discussion and feedback during a legislative meeting from June
With the development of the global economy, the growth of the total population and the aging of society, the demand for drugs is increasing, and the market size of the global pharmaceutical industry will maintain growth. stable.In 2023, the total global pharmaceutical market is estimated to be approximately US$1,6 trillion. This is an increase of
According to the Resolution, the Government of Vietnam highly appreciates the Ministry of Health of Vietnam for taking charge and cooperating with ministries and central authorities in actively preparing and presenting Bills according to the Law on Promulgation of Legislative Documents 2015; and Agrees on the necessity of the development of the Law on amendments
The top 10 businesses consist of Binh Thuan Plastic Group JSC, HD Securities Corporation, Orient Securities Corporation, Imedia Technology and Services JSC, SOL E&C Construction Investment JSC, Vietnam Vitadairy Milk JSC, Taseco Land Investment JSC, Stellapharm J.V. Co. Ltd., CNC Technology Solutions JSC, and Bee Logistics Corporation. The top 10 in the 2024 list of
Vietnamese pharmaceutical market grew from $2.7 billion in 2015 to $7 billion in 2022 and is forecast to reach more than $10 billion by 2026. The Vietnamese pharmaceutical industry is seeing great advantages.People’s spending on health was increasingly high giving pharmaceutical enterprises great potential for development, said Associate Professor, PhD. Lê Văn Truyền, former Deputy
Despite answering a number of state management requirements, the Pharmacy Law 2016 still displays certain inadequacies. Its amendments are supposed to provide patients with better access to new medication. To address inadequacies in the Law on Pharmacy 2016, the Government has already submitted a draft Law on Amendments for the Pharmacy Law 2016 to the
Under the People’s Committee of Ho Chi Minh City-approved project, the southern metropolis will have the country’s first largest medical and pharmaceutical industrial park. The city Department of Health today said that the municipal People’s Committee has just issued the Decision No. 657/QD-UBND to approve the Project ‘Developing Ho Chi Minh City’s pharmaceutical industry to
The amended Law on Pharmacy is key in ensuring comprehensive and adequate healthcare resources for the people. HÀ NỘI — Deputy Prime Minister Trần Hồng Hà emphasised that the amended Law on Pharmacy must include regulations to support foreign pharmaceutical enterprises to invest in drug production and technology transfer in Vietnam. Speaking at a meeting
Deputy Prime Minister Tran Hong Ha underlined the need to manage the pharmaceutical industry under market rules, ensuring publicity, transparency, quality control, safety, and cheapest prices during a meeting in Hanoi. Deputy Prime Minister Tran Hong Ha underlined the need to manage the pharmaceutical industry under market rules, ensuring publicity, transparency, quality control, safety, and
Drugs that are commonly used and have large volumes must be subject to centralized national or local bidding and selection of qualified manufacturers, Deputy Prime Minister Tran Hong Ha requested. Chairing a meeting on the draft decree guiding the 2023 Bidding Law on contractor selection, Deputy Prime Minister Tran Hong Ha said that in addition
Only 42 new drugs out of 460 types circulated globally are available in Vietnam, due to long licensing procedures and time, affecting patients. On January 21, a representative of the Ministry of Health said that generic drug prices in Vietnam are low compared to countries in the ASEAN region (for most main treatment groups). While
Innovative pharmaceuticals are emerging as a game-changer reshaping the industry, which is urging Vietnamese authorities to have supporting policies to tap into new potential. At Pfizer, new innovative vaccines are being studied to keep abreast of new viruses and bacteria that threaten human lives and livelihoods. They include a two-in-one flu and coronavirus jab, and
It is critical for pharmaceutical companies to improve competitiveness with a focus on research and development (R&D), production technology and digitalisation. According to experts, this will help them expand their shares in the domestic market which remains dominated by imported drugs and extend their international reach. Vietnam’s pharmaceutical market has significant potential. The Health Ministry
The Ministry of Health is drafting a Circular amending and supplementing a number of articles of Circular 29/2018/TT-BYT dated October 29, 10 of the Minister of Health regulating clinical drug trials. According to the provisions of Circular 29, regarding the legality of clinical drug trial records: The registration application and the content of the registration
Multinational corporations are giving priority to bringing more innovative medicines to Vietnam to tap into growing local demand. Pfizer plans to bring numerous innovative medicines to Vietnam over the next four years. This is in line with its global strategy, as the company has made significant progress towards launching 19 new products over an 18-month
The Ministry of Health has released a draft Law Amending the 2016 Law on Pharmacy, providing many attractive incentives for boosting the development of the pharmaceutical industry. The Ministry of Health (MOH) has released a draft Law Amending the 2016 Law on Pharmacy, providing many attractive incentives for boosting the development of the pharmaceutical industry.The
By 2030, Vietnam will become a center for manufacturing or processing of, and transfer of technologies for, brand-name medicines in the ASEAN region. Under Prime Minister Decision 1165/QD-TTg, approving the National Strategy for development of the domestic pharmaceutical industry through 2030, with a vision toward 2045, it is expected that the domestic pharmaceutical industry’s production
The pharmaceutical sector plays an important role in healthcare, meaning development goals must be established. Deputy Prime Minister Trần Hồng Hà made the statement on Wednesday afternoon after hearing a report on the draft National Strategy for the development of Việt Nam’s pharmaceutical sector by 2030. Hà said the draft strategy not only sets out
Medicine prices in Vietnam are in the lower range compared to those in other countries in the region, heard the Asian Federation for Pharmaceutical Sciences (AFPS) Conference 2023 that is taking place in Hanoi from November 8-10, 2023. Vice Health Minister Nguyen Thi Lien Huong speaks at the event (Photo: VNA) Themed “Collaboration for Breakthroughs
With a large population and a growing demand for pharmaceuticals, Vietnam currently ranks among the top 17 countries with the highest pharmaceutical industry growth rates globally. According to the Pharmaceutical Industry Development Program, by 2025, domestically produced drugs are expected to account for 75% of consumption and 60% of market value. Additionally, it is projected
New approaches for pharma-healthcare development in Vietnam were the main topic of discussion at a forum in Hanoi on July 20, 2023. At the event, held by the Dau tu (Investment Review) Newspaper, participants heard that the investment trend in the medicine and pharmacy fields changed a lot in the direction of focusing on innovation,
The lack of a breakthrough in vision and infeasible legal policies, worsened by complicated administrative procedures in pharmacy sector, are among limitations that make Vietnam less attractive to foreign investors. The lack of a breakthrough in vision and infeasible legal policies, worsened by complicated administrative procedures in pharmacy sector, are among limitations that make Vietnam
Vietnam has set a target of becoming a high-value pharmaceutical production center in the region under its strategy for the development of the pharmaceutical sector by 2030 with a vision to 2045. Under the strategy, which was approved by Deputy Prime Minister Tran Hong Ha on October 9, Vietnam will strive to develop its pharmaceutical
Vietnam is striving to develop the pharmaceutical industry to level 4, the highest as classified by the World Health Organisation, according to the National Strategy for Pharmaceutical Industry Development by 2023, with a vision toward 2045. Vietnam is striving to develop the pharmaceutical industry to level 4, the highest as classified by the World Health
LONDON, April 26, 2023 (Reuters) – Brussels on Wednesday published a long-awaited draft of its proposed overhaul of laws governing the European Union’s pharmaceuticals industry, setting up a tussle with drugmakers which warn they will invest and innovate elsewhere. The biggest overhaul of existing medical laws in two decades is aimed at ensuring all Europeans
The “Healthcare Innovation Forum”, a platform that brings together local and international experts to discuss and share experiences on innovative solutions in building a sustainable healthcare system worldwide and to drive the adoption of innovative approaches and technologies to transform healthcare in Vietnam. Diseases never stop developing, nor does innovation to deal with these obstacles.
The Ho Chi Minh City Department of Health is seeking feedback on the plan to construct a 300-hectare pharmaceutical industrial park during the 2025-30 period, a step to prepare for the city’s export of medical products in the future. The pharmaceutical industrial park is included in the draft project on the development of the pharmaceutical industry
The Circular is an important legal basis for attracting investment activities and transferring technology for drug production, especially original brand name drugs, patented drugs, specialized drugs, special treatments, and prescription drugs. generic drugs in the form of high-tech dosage forms, vaccines, reference biological products, and similar biological products according to the orientations in the “Program
Vietnam is focusing on improving research capacity and application of new drug production technology, promoting clinical pharmacy development and strengthening supervision of safe and reasonable drug use. Vietnam is focusing on improving research capacity and application of new drug production technology, promoting clinical pharmacy development and strengthening supervision of safe and reasonable drug use, aiming
On November 28, 2023, Vietnam Evaluation Report Joint Stock Company (Vietnam Report) officially announced the Top 10 prestigious Pharmaceutical Companies in 2023. Top 10 reputable Pharmaceutical Companies are built on scientific and objective principles. Companies are evaluated and ranked based on 3 main criteria: (1) Financial capacity shown on the most recent year’s financial statements;
Vietnam has set its sights on becoming a high-value pharmaceutical production hub within the region. Deputy Prime Minister Trần Hồng Hà recently backed a decision that has been hailed a significant milestone in Vietnam’s pharmaceutical sector. Signed on October 9, Decision No. 1165/QĐ-TTg has approved the National Strategy for developing Vietnam’s pharmaceutical industry until 2030,
The Ministry of Health is drafting a Circular promulgating a list of drugs, testing supplies, and medical equipment eligible for price negotiation and stipulating the process and procedures for selecting contractors for applicable bidding packages. form of price negotiation. According to the draft, the construction of the drug list is applied in the form of
It is critical for pharmaceutical companies to improve competitiveness with a focus on research and development (R&D), production technology and digitalisation. According to experts, this will help them expand their shares in the domestic market which remains being dominated by imported drugs and extend their international reach.Vietnam’s pharmaceutical market has significant potential. The Ministry of
As one of seven generic drug manufacturers selected by MPP and becoming a sub-licensee of Shionogi – a Japanese pharmaceutical manufacturer to produce of XOCOVA™ drug, generic version. Stellapharm is honored and proud to have contributed to repelling the COVID-19 pandemic with drugs. This is the third oral product in the world to be recognized
By Mr. Ong Van Dung, General Director, Stellapharm Stellapharm (former name was STADA-VN – a Joint Venture Pharmaceutical Company formed in 2002 with a Vietnamesecompany named M.S.T and German cooperation named STADA Arzneimittel). Stellapharm has become one of the leading generic pharmaceutical manufacturers in Vietnam, we follow the global quality standard in accordance with European
Major drugmakers are using artificial intelligence to find patients for clinical trials quickly, or to reduce the number of people needed to test medicines, both accelerating drug development and potentially saving millions of dollars. Human studies are the most expensive and time-consuming part of drug development as it can take years to recruit patients and
20 January 2022 Geneva – The Medicines Patent Pool (MPP) announced today that it has signed agreements with 27 generic manufacturing companies for the manufacturing of the oral COVID-19 antiviral medication molnupiravir and supply in 105 low- and-middle-income countries (LMICs). The sublicence agreements are the result of the voluntary licensing agreement signed by MPP and
Since the beginning of February this year, many consignments of Stella's pharmaceutical products with a total of nearly 200 million units have been urgently exported by air to markets in Germany, France, Austria, Belgium, Ireland, etc.
This will be the first steroid-hormone pharmaceutical factory in Vietnam and among a few ASEAN factories built in compliance with European Standards for this line of products.
Due to our strategic development of the Company, we are pleased to announce the change of Company Name: STADA - VN JOINT VENTURE CO., LTD. officially changed its name to STELLAPHARM J.V. CO., LTD. since 16 August 2019. Address, Tax code, Telephone/Fax Number remains unchanged.
“Accrediting the fifth EU-GMP is one of our commitment on maintaining highest EU standards and quality of products with affordable prices” said by Choo Yan Ho, the Chairman.
On 15 March 2016, the fourth EU-GMP Inspection was conducted at STADA – VN J.V. Co., Ltd., Binh Duong Branch, currently known as STELLAPHARM J.V. Co., Ltd. – Branch 1
On 06 January 2015, STADA – VN J.V. Co., Ltd., Binh Duong Branch (the “STELLA” or “Factory II“), was appreciated by Ministry of Health, Labour and Welfare (the "MHLW") issued the certificate of Japan GMP for the product of Soleton 80 with its composition and strength: Zaltoprofen 80 mg
On 19 March 2013, the third EU-GMP Inspection was conducted in five continuous days at STADA – VN J.V. Co., Ltd., Binh Duong Branch (the “Company” or “Factory II“), located at Vietnam – Singapore Industrial Park, Binh Duong and the Factory II was recognized as a pharma facility complying with European Good Manufacturing Practice issued
Sorafenib STELLA 200 mg is indicated for the treatment of certain advanced cancers such as liver cancer, kidney cancer, and differentiated thyroid cancer resistant to radioiodine.
Abiraterone 250 mg (as abiraterone acetate) is an endocrine therapy (hormone therapy) used to treat advanced or metastatic prostate cancer. Abiraterone STELLA 250 mg works by blocking the body's production of the male sex hormone (testosterone) to slow tumor growth.
Anastrozole is an aromatase inhibitor used to treat hormone receptor-positive breast cancer in postmenopausal women. Anastrozole STELLA 1 mg is a film-coated tablet, 1 mg (1 tablet) taken orally once daily and should be used as directed by a doctor.
Letrozole STELLA 2.5 mg (Letrozole 2,5 mg) belongs to antineoplastic and immunomodulating agents, aromatase inhibitors, indicated in adjuvant treatment of postmenopausal women with hormone receptorpositive invasive early breast cancer.
Capecitabine STELLA 500 mg (Capecitabine 500 mg) is an oral cancer drug, indicated for the treatment of colon cancer, stomach cancer, and breast cancer, may be used alone or in combination with other drugs depending on the stage of the disease.
Aztezan (Azithromycin 500mg) is indicated for treatments respiratory tract infections (pneumonia, bronchitis), skin and soft tissue infections, middle ear infections, and sexually transmitted diseases. Azithromycin is well tolerated with a low incidence of undesirable effects. Aztezan is manufactured by Stellapharm under technology transfer of Auxilto Healthcare GmbH (Germany).
Donestad 10 (Donepezil hydrochloride 10mg) is an acetylcholinesterase inhibitor prescribed for the treatment of mild to moderate to severe dementia symptoms in Alzheimer's disease. Donestad 10 is not recommended for use in children and adolescents below 18 years of age.
Zanladyne 8 (Galantamine 8 mg) is an anticholinesterases indicated for the symptomatic treatment of mild to moderately severe dementia of the Alzheimer type. The medication helps improve cognition and daily functioning by increasing acetylcholine levels in the brain.
Paroxetine STELLA 20 mg (paroxetine 20 mg) are primarily used as antidepressant and anti-anxiety medications. Paroxetine produces no clinically significant changes in blood pressure, heart rate and ECG after administration to healthy subjects.
Sertraline 50 mg is indicated for the treatment of major depressive episodes, panic disorder with or without agoraphobia, obsessive compulsive, social anxiety disorder, post traumatic stress disorder.
Gabapentin 300 mg is indicated for the treatment of neuropathic pain such as painful diabetic neuropathy and post-herpetic neuralgia in adults. Safety and effectiveness in patients younger than 18 years have not been established.
Partamol 150 Supp. (paracetamol 150 mg) is reserved for symptomatic treatment of mild to moderate pain and/or feverish states in infants weighing 8 to 12 kg (approximately 6 to 24 months).
Paracetamol is an effective alternative to aspirin as an analgesic-antipyretic agent; however, it is not a useful agent to treat inflammatory conditions. Paracetamol lowers body temperature in patients with fever but rarely lowers normal body temperature.
Stadsidon 20 (ziprasidone 20 mg) is indicated in treatment of bipolar I disorder, treatment of schizophrenia and acute treatment of agitation in schizophrenia.
Sumastad 100 (Sumatriptan 100 mg) are indicated for the acute treatment of migraine attacks, with or without aura. Sumatriptan should only be used where there is a clear diagnosis of migraine.
Vinpocetine is indicated in treatment of Cerebral circulatory disorders of various origins. Alleviation of the mental and neurological symptoms of cerebral circulatory disorders. Treatment of certain ear and eye diseases with vascular causes, or relieve symptoms of these diseases.
Erdostella 300 (Erdosteine 300 mg) belongs to the mucolytic class of drugs that reduce the viscosity of mucus and phlegm, treating the symptoms of acute exacerbations in chronic bronchitis in adults.
Ambroxol hydrochloride 30 mg (Ambroxol hydrochloride) has mucokinetic and expectorant properties in acute and chronic diseases of the respiratory tract accompanied by abnormal bronchial secretions.
Ambroxol, the main active ingredient of Ambroxol Auxilto 30 mg, is a metabolite of bromhexine, belonging to the benzylamine group of mucolytic compounds, used as an expectorant in the treatment of respiratory diseases.
Amxolstad 15 tablets (Ambroxol 15 mg) are indicated for the treatment of respiratory diseases and to promote drainage in chronic sinusitis.
Stebastin 20 (Ebastine 20 mg) is indicated in treatment of symptoms of urticaria, severe allergic rhinitis, with or without allergic conjunctivitis.
Clenmysol Tab. is indicated for acute and chronic respiratory conditions associated with bronchospasm and altered secretion formation and transport, particularly spastic bronchitis, emphysematous bronchitis, and bronchial asthma.
Helix STELLA containing dried ivy leaf extract (Hedera helix L.) is used for adults and children above 1 in dry cough, productive cough, cough due to weather change, sore throat, bronchitis. This product is health supplement, not approved therapeutics claims.
Helix STELLA FORTE containing dried ivy leaf extract (Hedera helix L.) helps relieve cough and reduce phlegm.
G.Samin Forte (Glucosamine sulfate potassium chloride, Chondroitin sulfate sodium, Black pepper dry extract) helps support the improvement of joint pain and mobility difficulties in adults.
Simarin plus with combination of silymarin (from Milk Thistle extract) with Vitamin B1, B6, B12 helps improve liver function and jaundice due to poor liver function.
Estrostad capsules contain herbal ingredients (Angelica gigas, Cynanchum wilfordii, and Phlomis umbrosa) that help manage premenopausal-related issues. This health supplement is not therapeutic claimed.
Rutin-C STELLA (Rutin trihydrate combined with ascorbic acid) helps increase vascular endurance, supports antioxidant activity and promotes cardiovascular health in adults.
Ferolina (Zinc fumarate, spirulina powder, folic acid, vitamin B12) helps reduce the risk of zinc deficiency anemia, supports the process of blood formation in adults and children over 10 years old.
Supplements folic acid for the body. Supports increasing blood formation. Helps reduce anemia due to folic acid deficiency,
CoQ10-STELLA contains Coenzyme Q10 and black pepper extract, supports antioxidant activity and promotes cardiovascular health in adults. This product is not approved therapeutic claims.
Tauginko 250 STELLA contains taurine and ginkgo leaf extract for adults with cerebral circulatory insufficiency. This product is not a medicine and does not replace prescription medication.
VitK-D STELLA (Vitamin K2, vitamin D3) is for adults at risk of osteoporosis due to vitamin D deficiency and for children from 6 months of age at risk of rickets. This product is not approved therapeutic claims.
ZinDcal (Calcium, Magnesium, Zinc, Vitamin D3) supports enhanced calcium absorption, helps strengthen bones and teeth, aids in height development, reduces the risk of rickets in children, and decreases the risk of osteoporosis in adults.
The combination of glibenclamide (an insulin-stimulating drug) and metformin hydrochloride (an insulin resistance-reducing drug) is a common treatment regimen for type 2 diabetes in adults. This synergistic drug helps control blood glucose more effectively due to its dual mechanism of action and is often prescribed when diet, exercise, and monotherapy are ineffective.
Empagliflozin STELLA 25 mg (Empagliflozin 25 mg) is a medication used to treat type 2 diabetes and reduce the risk of cardiovascular death and heart failure. It works by increasing glucose excretion in the urine, typically at a dose of 10-25 mg/day, taken in the morning.
Vildagliptin is used in the treatment of type 2 diabetes in adults (Monotherapy for patients who are not adequately controlled by diet and exercise, and/or in combination with other antidiabetic agents).
Sitagliptin in Gliptinestad 100 is indicated for type 2 diabetes mellitus in patient has previously performed diet and exercise without achieving results.
Ondanstella 4 (Ondansetron 4 mg) is an antiemetic drug belonging to the 5-HT3 receptor antagonist class. It works by blocking nausea signals from reaching the brain and is primarily indicated for the prevention and control of nausea caused by chemotherapy, radiation therapy, or surgery.
Auxilprazol 40/1100 (Omeprazole 40 mg, Sodium bicarbonate 1100 mg) is indicated for adults in treatment of active duodenal ulcer, benign gastric ulcer, gastroesophageal reflux disease.
Rebagastrin (Rebamipide 100 mg) belongs to the group of drugs used for treatment gastric and duodenal ulcers and gastroesophageal reflux disease in adults.
Racetril Cap. (racecadotril 100 mg)is reserved for symptomatic treatment of acute diarrhoea in adults. Racecadotril decreases the intestinal hypersecretion of water and electrolytes induced by cholera toxin or inflammation, and does not have effects on basal secretory activity.
Allostella 3G (L-ornithine L-aspartate 3000 mg) oral granules is for the treatment of concomitant disease and sequelae due to impaired hepatic detoxification activity. Allostella 3G is dissolved in plenty of fluid (e.g. a glass of water, tea or juice) and taken with or after meals.
Simethicone does not affect gastric acid secretion or nutrient absorption. Ex-gas TAB 80 (Simethicone 80 mg) helps reduce bloating and abdominal distension caused by gas accumulation in the gastrointestinal tract in adults.
In both healthy subjects and patients with hypercholesterolaemia, pravastatin sodium lowers the following lipid values: total cholesterol, LDL-cholesterol, apolipoprotein B, VLDL-cholesterol and riglycerides; while HDL-cholesterol and apolipoprotein A are elevated.
At the recommended dose, ivabradine helps reduce heart rate by approximately 10 beats per minute at rest and during exercise. Ivabradine STELLA 7.5 mg helps reduce the burden on the heart during activity and decreases the oxygen demand of the myocardium.
Plestastad 50 (Cilostazol 50 mg) is a medication for vascular diseases that works by inhibiting platelet aggregation and dilating blood vessels. This medication helps improve blood flow and is often used to reduce leg pain during walking, increasing walking distance in people with intermittent claudication.
Stefamlor 5/20 (amlodipine 5 mg and atorvastatin 20 mg) is indicated for patients with cardiovascular disease who require treatment for both hypertension and high cholesterol levels or angina.
Stadlacil 4 (Lacidipine 4 mg) is indicated for the treatment of hypertension as monotherapy or in combination with other antihypertensive agents such as beta-blockers, diuretics and ACE inhibitors.
Ramistell 5 (Ramipril 5 mg) is indicated for the treatment of high blood pressure, heart failure, and to reduce the risk of myocardial infarction/stroke. The drug works by dilating blood vessels, helping to lower blood pressure and reduce the burden on the heart.
Cilnistella 5 (Cilnidipine 5 mg) is a calcium channel blocker used as an antihypertensive medication, it is beneficial for the cardiovascular system in adults.
Creswell 80 (Sotalol hydrochloride 80 mg) belongs to non-selective beta-adrenergic blockers (class II) and class III antiarrhythmics, are used to treat ventricular arrhythmias, atrial fibrillation, and atrial flutter. They work by slowing the heart rate, maintaining a normal sinus rhythm, and preventing the recurrence of arrhythmias.
Castella 90 (Ticagrelor) is co-administered with acetylsalicylic in the prevention of atherothrombotic events in adult patients with acute coronary syndromes and with history of myocardial infarction and a high risk of developing an atherothrombotic event.
Simvastatin and ezetimibe combination along with a proper diet to help lower "bad" cholesterol and fats (such as LDL-C, triglycerides) and increase "good" cholesterol (HDL-C) in the blood to help reduces the risk of heart disease, an intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia.
Amiodarone is an antiarrhythmic drug used to treat and prevent certain types of arrhythmias. These arrhythmias include ventricular tachycardia, ventricular fibrillation, and wide QRS tachycardia, as well as atrial fibrillation and paroxysmal supraventricular tachycardia. However, evidence in cardiac arrest is limited.
Xelostad 10 (Rivaroxaban) is used for prevention of venous thromboembolism (VTE) in adult patients, treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.
Ezecept 20/10 containing ezetimibe and atorvastatin, is a lipid-lowering agent that selectively inhibits the intestinal absorption of cholesterol and related phytosterols and inhibits endogenous cholesterol synthesis.
Nitroglycerin belongs to the group of organic nitrates. The Nitrostad 0.6 sublingual tablet containing 0.6 mg of nitroglycerin has a vasodilatory effect, helping to improve blood circulation, thereby preventing the recurrence of angina (due to inadequate blood supply to the heart)
Clobetad (Clobetasol 0.05%) is a topical corticosteroid, commonly used in short term treatment of more resistant inflammatory and pruritic manifestations of steroid responsive dermatoses unresponsive to less potent corticosteroids.
Stadgentri is a topical cream combining the anti-inflammatory, antipruritic actions of betamethasone with the antifungal activity of clotrimazole and the broad-spectrum antibiotic activity of gentamicin sulfate.
Dequalinium chloride is a quaternary ammonium compound with broad-spectrum antiseptic, antifungal, and antimicrobial effects, most commonly available as 10mg vaginal suppositories (e.g., Aliquina) to treat bacterial and fungal vaginal infections and Trichomonas infections. The drug acts locally, is fast-acting, has minimal systemic absorption, and is safe for pregnant and breastfeeding women.
Vastad (Metronidazole, nystatin and neomycin sulfate) belongs to antiinfectives and antiseptics pharmacotherapeutic group, excluding combinations with corticosteroids, effective treatment for vaginitis caused by all factors, including bacteria, trichomonas, and fungi.
Nordrone 5 (Norethindrone 5 mg) is a synthetic progestin hormone indicated in treatments endometriosis, amenorrhoea, dysfunctional bleeding, premenstrual syndrome, cyclical mastopathy, timing of menstruation.
Dapostella 30 (Dapoxetine 30 mg) is prescriped to treat premature ejaculation in men aged 18-64. It works by inhibiting neurotransmitters, helping to control ejaculation and improve the duration of intercourse.
Predstad 20 ontains prednisolone as its active ingredient, indicated for the treatment and/or suppression of inflammatory and allergic disorders. The drug is in the form of water-dispersible tablet.
Deflazacort is in a class of medications called corticosteroids. Its antiinflammatory and immunosuppressive effects are used in treating asthma, arthritis, immune suppression in transplantation.
Molnupiravir is indicated for the treatment of mild to moderate COVID-19 disease in adults with a positive diagnostic test for SARS-CoV-2 and with at least one risk factor for severe disease progression.
Molnupiravir STELLA 400 mg (Molnupiravir 400 mg) is indicated for the treatment of mild to moderate COVID-19 disease in adults with a positive diagnostic test for SARS-CoV-2 and with at least one risk factor for severe disease progression.
Tefostad T300 (Tenofovir disoproxil fumarate) is used in conjunction with other antiretroviral agents (should not be used alone) in the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults, post-exposure prophylaxis of HIV infection and in treatment of chronic hepatitis B in adults.
Entecavir STELLA 0.5 mg is used in treatment of chronic hepatitis B in adults.
Metronidazole STELLA 400 mg contains metronidazole that derivative with activity against anaerobic bacteria and protozoa. It is used for treatment of susceptible protozoal infections, treatment and prophylaxis of anaerobic bacterial infections, eradicate Helicobacter pylori in peptic ulcer disease, Colonic Crohn's disease.
Clindamycin STELLA 150 mg is used in prevention of endocarditis or infection due to surgical implant, lung abscess, severe respiratory tract infections, etc.
S-Profen 200 (Dexibuprofen 200 mg) is an anti-inflammatory and anti-rheumatic product, non-steroids, has an analgesic, anti-inflammatory and anti-pyretic effect in osteoarthritis.
Uprofen 200 (Ibuprofen 200 mg) is an NSAID pain reliever and anti-inflammatory drug commonly used to reduce fever, relieve headaches, menstrual cramps, and mild to moderate musculoskeletal pain. It should be taken after a full meal to minimize stomach irritation.
Fencopain 50 (Flurbiprofen 50 mg) is used in the treatment of arthritis. Additionally, it helps reduce symptoms in musculoskeletal disorders and injuries. Fencopain 50 also provides relief from mild to moderate pain, including toothache, post-surgical pain, menstrual cramps, and migraines.
Naproflam 250 (Naproxen 250 mg) is a non-steroidal anti-inflammatory analgesic compound with antipyretic properties. Naproxen inhibits prostaglandin synthetase (as do other NSAIDs).
Etoricoxib 120 mg is a selective COX-2 inhibitor, a non-steroidal anti-inflammatory drug (NSAID), commonly prescribed for short-term acute pain relief (post-dental surgery pain), symptomatic treatment of arthritis attacks, and treatment of acute gout attacks. The drug works by reducing swelling and inflammation.
Ecoxia 30 (Etoricoxib 30 mg) is a non-steroidal anti-inflammatory drug (NSAID) that selectively inhibits COX-2, used to reduce pain and inflammation in osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, acute pain. The usual dose is 30-60 mg once daily. It requires a prescription and long-term use should be avoided due to cardiovascular and gastrointestinal risks.
Stadolac 200 (etodolac 200mg) is a nonsteroidal anti-inflammatory drug (NSAID) that exhibits antiinflammatory, analgesic, and antipyretic activities. It is indicated for the management of pain in osteoarthritis, rheumatoid arthritis.
Zanastad reduces motor neurons stimulation on the spinal cord, therefore reducing muscle spasm and not producing excessive muscle weakness.
Chewable tablet Mestad 500 (Mebendazole 500 mg) in a dosage of one single tablet only is to treat the symptoms of intestinal worms.
Azoltel 400 contains albendazole, a benzimidazole carbamate derivative which is structurally related to hiabendazole and mebendazole. It has a wide spectrum of activity against intestinal nematodes.
Bicimax (Vitamin B Complex, Vitamin C, Calcium and Magnesium) is used for supplementation of deficiencies of the vitamins B complex, vitamin C, calcium and magnesium: e.g., prolonged stress, prolonged infection and fever, intestinal diseases, gastrectomy, alcohol abuse.
Pravitce contains calcium and vitamin C. Its main use is to supplement these two substances for people suffering from nutritional deficiencies, during pregnancy, lactation, adolescents during growth, and the elderly.
Elnitine (Magnesium gluconate, Calcium glycerophosphate) is used for supplementation of calcium and magnesium in for patients in convalescence, stress, elderly patients, menopausal women, children in growth.
The combination of calcium and vitamin D3 in Caltab-Stella 1250/125 film-coated tablets is an essential formula for treating and preventing calcium deficiency. Adequate calcium intake helps reduce the risk of osteoporosis.
